Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Heterocyclic carbon compounds containing a hetero ring...
Patent
1989-12-28
1992-05-05
Schenkman, Leonard
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Heterocyclic carbon compounds containing a hetero ring...
514863, A61K 3155
Patent
active
051108143
ABSTRACT:
The use of azelastine or its therapeutically acceptable salts and the preparation of a pharmaceutical composition for the treatment of inflammatory disorders and psoriasis disorders.
REFERENCES:
patent: 4871733 (1989-10-01), Sunshine et al.
M. Kondo, Jpn. J. Clin. Ophthalmol. 42, (1988), p. 781.
N. Chand, Br. J. Pharmacol. 87 (2), (1986), p. 443.
N. Chand, Allergy, 41, (1986), p. 473.
K. Taniguchi, Biochem. Pharmacol., 33 (20), (1984), p. 3165.
J. G. Massicot, Prostaglandins, 32 (4), (1986), p. 481.
Arzneim.-Forsch/Drug Res., 31 (2), 8, (1981), pp. 1212-1215, 1184-1193, 1193-1195, 1196-1203 and 1203-1206.
Arerugi, 1987, 36 (2), pp. 108-111 (CA-107:33156m).
Agents Actions, 1989, 26 (1-2), pp. 70-72 (CA-110:88346r).
Gastroenterol. Jpn., 1988, 23 (3), pp. 263-267 (CA-109:108425a).
J. Pharm. Pharmacol., 1988, 40 (3), p. 225 (CA-108:197821w).
Eur. J. Pharmacol., 1988, 148 (1), pp. 35-41 (CA-108:179821s).
Int. Arch. Allergy Appl. Immunol., 1987, 83 (3), pp. 284-290 (CA-107:70437z).
Chemical Abstracts 95:180848a (1981).
Engel Jurgen
Molliere Michael
Szelenyi Istvan
Asta Pharma AG
Schenkman Leonard
LandOfFree
Azelastine and its salts used to combat psoriasis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Azelastine and its salts used to combat psoriasis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Azelastine and its salts used to combat psoriasis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1412565